Back to Authors

Jenks, Nathan

A5110264713 | I1330342723

Mayo Clinic

Citations 5

Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice

Human Gene Therapy | October 25, 2019 | Volume: 31 | Issue: 1-2 | Pages: 70-79

10.1089/hum.2019.233 | PMID 31650869

Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice

Human Gene Therapy Clinical Development | September 7, 2016 | Volume: 27 | Issue: 4 | Pages: 145-151

10.1089/humc.2016.062 | PMID 27604429

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS

Human Gene Therapy Clinical Development | August 17, 2016 | Volume: 27 | Issue: 3 | Pages: 111-122

10.1089/humc.2016.061 | PMID 27532609

Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs

Human Gene Therapy Clinical Development | November 12, 2013 | Volume: 24 | Issue: 4 | Pages: 174-181

10.1089/humc.2013.165 | PMID 24219832

Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates

Human Gene Therapy | November 13, 2009 | Volume: 21 | Issue: 4 | Pages: 451-462

10.1089/hum.2009.111 | PMID 19911974